Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Schweppe K. W. Progestins and uterine leiomyoma. Gynecol. Endocrinol., 1999; 13 Suppl 4:21–24.

Scialli A. R. Developmental effects of progesterone and its derivatives. Reprod. Toxicol., 1988; 2:3–11.

Scott J. R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev., 2003; 1:CD000112.

Scully C., et al. Metabolism of progesterone by human leukocytes. Clinical Immunology and Immunopthology, 1982; 22:147–151.

Shahar E., Bergman R., Pollack S. Autoimmune progesterone dermatitis: effective prophylactic treatment with danazol. Int. J. Dermatol., 1997; 36:708–711.

Shanker Y. G., Sharma S. C., Rao A. J. Expression of progesterone receptor mRNA in the first trimester human placenta. Biochem. Mol. Biol. Int., 1997; 42:1235–1240.

Shaw W. The Origin of the Lutein Cells of the Corpus Luteum. Proc. R. Soc. Med., 1926; 19 (Obstet. Gynecol. Sect.): 22–24.

Sheehan T., Numan M. Estrogen, progesterone, and pregnancy termination alter neural activity in brain regions that control maternal behavior in rats. Neuroendocrinology, 2002; 75:12–23.

Sherman B. M., West J. H., Korenman S. G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metabol., 1976; 42:629–636.

Shi J., Simpkins J. W. 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am. J. Physiol., 1997; 272:E1016–E1022.

Shirkey H. C. Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs. Adv. Exp. Med. Biol., 1972; 27:17–30.

Shkolnik K., et al. Reactive oxygen species are indispensable in ovulation. PNAS, January 25, 2011; 108 (4):1462–1467.

Shultz T. D., Howie B. J. In vitro binding of steroid hormones by natural and purified fibers. Nutr. Cancer, 1986; 8:141–147.

Siiteri P. K., Febres F., Clemens L. E. Progesterone and maintenance of pregnancy: is progesterone nature’s immunosuppressant? Ann. NY. Acad. Sci., 1977; 286:384–397.

Sills E. S., Alper M. M., Walsh A. P. H. Ovarian reserve screening in infertility: Practical applications and theoretical directions for research. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009; 146:30–36.

Silver R. I., et al. In vitro fertilization is associated with an increased risk of hypospadias. J. Urol., 1999; 161:1954–1957.

Silver R. I. Endocrine abnormalities in boys with hypospadias. Adv. Exp. Med. Biol., 2004; 545:45–72.

Šimić N., Santini M. Verbal amd spatial functions during different phases of the menstrual cycle. Psychiatria Danubina, 2012; 24 (1):73–79.

Simon J. A., et al. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril., 1993; 60:26–33.

Simon J. A. Micronized progesterone: vaginal and oral uses. Clin. Obstet. Gynecol., 1995; 38:902–914.

Simoncini T., et al. Effects of dydrogesterone and of its stable metabolite, 20-a-dihydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil. Steril., 2006; 86 (Suppl 3):1235–1242.

Simoncini T., et al. In vitro effects of progesterone and progestins on vascular cells. Steroids, 2003; 68:831–836.

Singh M., Su C. Progesterone and neuroprotection. Horm. Behav., 2013; 63 (2):284–290.

Singh M. Progesterone-Induced Neuroprotection. Endocrine, 2006; 29 (2):271–274.

Sirrat G. M. Recurrent miscarriage. Lancet, 1990; 336:673–675.

Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 2002; 9:6–15.

Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet. Gynecol., 1991; 78:291–298.

Slotta K.H., Ruschig H., Fels E. Reindarstellung der Hormone aus dem Corpusluteum. Berichte Deutsche chemische Gesellschaft, 1934; 67 (7):1270–1273.

Smith L. J., et al. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology, 2004; 29:2035–2045.

Smitz J., et al. A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route. Rev. Fr. Gynecol. Obstet., 1992; 87:507–516.

Snyder J. L., Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann. Allergy Asthma Immunol., 2003; 90:469–477.

Soares C. N., et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a doubleblind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry, 2001;58:529–534.

Soares S. R., et al. Cigarette smoking affects uterine receptiveness. Hum. Reprod., 2007; 22:543–547.

Soliz J., Joseph V. Perinatal steroid exposure and respiratory control during early postnatal life. Respir. Physiol. Neurobiol., 2005; 149:111–122.

Somers S. Ageless: The Naked Truth about Bioidentical Hormones. New York, NY: Crown Publishers; 2006.